{"id":149,"date":"2026-06-18T00:09:00","date_gmt":"2026-06-18T00:09:00","guid":{"rendered":"https:\/\/peptidesdivas.com\/?post_type=product&#038;p=149"},"modified":"2026-07-20T08:32:05","modified_gmt":"2026-07-20T08:32:05","slug":"tesamorelin-research-peptide-peptides-divas","status":"publish","type":"product","link":"https:\/\/peptidesdivas.com\/cs\/product\/tesamorelin-research-peptide-peptides-divas\/","title":{"rendered":"Tesamorelin"},"content":{"rendered":"<h1>Tesamorelin \u2013 Stabilised GHRH Analogue for Research<\/h1>\n<p>Tesamorelin is an advanced synthetic analogue of human growth hormone-releasing hormone, also known as GHRH or growth hormone-releasing factor. It contains the complete 44-amino-acid sequence of human GRF with a specialised N-terminal trans-3-hexenoyl modification.<\/p>\n<p>This molecular modification supports improved resistance to rapid enzymatic degradation and gives Tesamorelin a more stable research profile than naturally occurring GHRH.<\/p>\n<p>Its clearly defined structure makes Tesamorelin particularly relevant for professional laboratory studies involving GHRH receptor activity, pituitary signalling, endogenous growth hormone release, the GH\u2013IGF-1 axis and stabilised peptide development.<\/p>\n<p>Tesamorelin is supplied as a premium lyophilised research material in a securely sealed vial with clear batch information, professional packaging and fast order processing from Peptides Divas.<\/p>\n<h2>Kl\u00ed\u010dov\u00e9 vlastnosti produktu<\/h2>\n<ul>\n<li>Synthetic human GHRH analogue<\/li>\n<li>Complete 44-amino-acid peptide sequence<\/li>\n<li>Also known by the research designation TH9507<\/li>\n<li>Specialised N-terminal hexenoyl modification<\/li>\n<li>Designed for improved molecular stability<\/li>\n<li>Relevant for GHRH receptor research<\/li>\n<li>Suitable for pituitary signalling studies<\/li>\n<li>Useful for GH and IGF-1 pathway research<\/li>\n<li>Dod\u00e1v\u00e1 se jako lyofilizovan\u00fd v\u00fdzkumn\u00fd materi\u00e1l<\/li>\n<li>Jasn\u00e9 informace o produktu specifick\u00e9 pro danou \u0161ar\u017ei<\/li>\n<li>Bezpe\u010dn\u00e9 a diskr\u00e9tn\u00ed balen\u00ed<\/li>\n<li>Rychl\u00e9 a sledovateln\u00e9 doru\u010den\u00ed do Evropy<\/li>\n<\/ul>\n<h2>What Is Tesamorelin?<\/h2>\n<p>Tesamorelin is a synthetic peptide based on the complete amino-acid sequence of naturally occurring human growth hormone-releasing hormone.<\/p>\n<p>Natural GHRH is produced in the hypothalamus and communicates with specialised receptors located on somatotroph cells within the anterior pituitary. This signalling system is involved in regulating the synthesis and pulsatile release of endogenous growth hormone.<\/p>\n<p>Naturally occurring GHRH is rapidly broken down by enzymes. Tesamorelin contains an N-terminal trans-3-hexenoyl group attached to its tyrosine residue, creating a stabilised GHRH analogue suitable for extended peptide and receptor research.<\/p>\n<h2>Molecular Structure<\/h2>\n<p>Tesamorelin contains 44 amino acids and retains the complete sequence of human GRF.<\/p>\n<p>Its structural characteristics include:<\/p>\n<ul>\n<li>Complete human GRF 1\u201344 sequence<\/li>\n<li>N-terminal tyrosine residue<\/li>\n<li>Trans-3-hexenoyl molecular modification<\/li>\n<li>C6 carbon chain containing a double bond<\/li>\n<li>Stabilised synthetic peptide structure<\/li>\n<li>GHRH receptor agonist activity<\/li>\n<li>Approximate molecular weight of 5.1 kDa<\/li>\n<li>Commonly prepared and analysed as an acetate salt<\/li>\n<\/ul>\n<p>The hexenoyl modification differentiates Tesamorelin from unmodified human GHRH and shorter GHRH fragments.<\/p>\n<h2>V\u00fdzkum receptor\u016f GHRH<\/h2>\n<p>Tesamorelin is primarily studied in relation to the growth hormone-releasing hormone receptor.<\/p>\n<p>The GHRH receptor is a G-protein-coupled receptor expressed mainly on pituitary somatotroph cells. Activation of this receptor initiates intracellular signalling associated with growth hormone synthesis and secretion.<\/p>\n<p>Potential areas of laboratory research include:<\/p>\n<ul>\n<li>Vazba na receptor GHRH<\/li>\n<li>Aktivace receptoru<\/li>\n<li>Interakce ligand-receptor<\/li>\n<li>Cyklick\u00e1 AMP signalizace<\/li>\n<li>Intracellular calcium pathways<\/li>\n<li>Pituitary somatotroph activity<\/li>\n<li>Internalizace receptor\u016f<\/li>\n<li>Citlivost receptoru<\/li>\n<li>Vztahy mezi koncentrac\u00ed a odezvou<\/li>\n<li>Comparative GHRH analogue pharmacology<\/li>\n<\/ul>\n<p>The exact experimental conditions and analytical methods should be established by the qualified laboratory conducting the research.<\/p>\n<h2>Pituitary Signalling Research<\/h2>\n<p>The anterior pituitary is an important endocrine signalling centre responsible for releasing several protein and peptide hormones.<\/p>\n<p>Tesamorelin may be relevant for controlled laboratory studies involving:<\/p>\n<ul>\n<li>Somatotroph-cell signalling<\/li>\n<li>Endogenous growth hormone release<\/li>\n<li>Pulsatile hormone secretion<\/li>\n<li>Pituitary receptor expression<\/li>\n<li>Intracelul\u00e1rn\u00ed sign\u00e1ln\u00ed transdukce<\/li>\n<li>Hormone-release kinetics<\/li>\n<li>Hypothalamic\u2013pituitary communication<\/li>\n<li>Endokrinn\u00ed mechanismy zp\u011btn\u00e9 vazby<\/li>\n<li>Comparative pituitary-cell assays<\/li>\n<li>GHRH-mediated cellular responses<\/li>\n<\/ul>\n<p>Tesamorelin stimulates the GHRH pathway rather than acting as recombinant growth hormone itself.<\/p>\n<h2>GH\u2013IGF-1 Axis Research<\/h2>\n<p>The growth hormone and insulin-like growth factor 1 axis forms an interconnected endocrine signalling network.<\/p>\n<p>GHRH receptor activation in the pituitary can influence endogenous growth hormone secretion. Growth hormone subsequently participates in signalling associated with IGF-1 production and broader endocrine feedback systems.<\/p>\n<p>Tesamorelin may therefore be studied in relation to:<\/p>\n<ul>\n<li>Growth hormone pulsatility<\/li>\n<li>GH secretion patterns<\/li>\n<li>IGF-1-associated signalling<\/li>\n<li>Endocrine feedback loops<\/li>\n<li>Hypothalamic\u2013pituitary communication<\/li>\n<li>Anal\u00fdza hormon\u00e1ln\u00edch biomarker\u016f<\/li>\n<li>Metabolic signalling pathways<\/li>\n<li>Protein-turnover mechanisms<\/li>\n<li>Comparative endocrine models<\/li>\n<li>Time-dependent hormone responses<\/li>\n<\/ul>\n<p>These pathways describe areas of scientific interest and should not be interpreted as guaranteed effects from a non-pharmaceutical research material.<\/p>\n<h2>Stabilised Peptide Research<\/h2>\n<p>The N-terminal hexenoyl modification makes Tesamorelin particularly relevant for research into peptide stabilisation and molecular engineering.<\/p>\n<p>Potential research topics include:<\/p>\n<ul>\n<li>Resistance to enzymatic degradation<\/li>\n<li>N-terminal peptide modification<\/li>\n<li>Prodlou\u017een\u00ed molekul\u00e1rn\u00edho polo\u010dasu<\/li>\n<li>Peptide clearance<\/li>\n<li>Vztahy mezi strukturou a aktivitou<\/li>\n<li>Long-acting peptide design<\/li>\n<li>Peptide pharmacokinetics<\/li>\n<li>Modified GHRH analogues<\/li>\n<li>Molekul\u00e1rn\u00ed stabilita<\/li>\n<li>Peptide formulation development<\/li>\n<\/ul>\n<p>Researchers may compare Tesamorelin with native GHRH, sermorelin, Modified GRF 1\u201329 or other GHRH-related compounds.<\/p>\n<h2>Tesamorelin Versus Sermorelin<\/h2>\n<p>Tesamorelin and sermorelin are both related to human GHRH, but they are not identical compounds.<\/p>\n<table>\n<thead>\n<tr>\n<th>Charakteristick\u00fd<\/th>\n<th>Tesamorelin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Peptidov\u00e1 sekvence<\/td>\n<td>Human GRF 1\u201344<\/td>\n<\/tr>\n<tr>\n<td>D\u00e9lka peptidu<\/td>\n<td>44 amino acids<\/td>\n<\/tr>\n<tr>\n<td>Molekul\u00e1rn\u00ed modifikace<\/td>\n<td>N-terminal trans-3-hexenoyl group<\/td>\n<\/tr>\n<tr>\n<td>Primary receptor<\/td>\n<td>GHRH receptor<\/td>\n<\/tr>\n<tr>\n<td>V\u00fdzkumn\u00fd profil<\/td>\n<td>Stabilised full-length GHRH analogue<\/td>\n<\/tr>\n<tr>\n<td>Alternative designation<\/td>\n<td>TH9507<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Sermorelin generally refers to the shorter GHRH 1\u201329 sequence and does not contain the same hexenoyl modification.<\/p>\n<h2>Tesamorelin Versus CJC-1295<\/h2>\n<p>Tesamorelin and CJC-1295 are both synthetic GHRH-related peptides, but their structures and stabilisation strategies differ.<\/p>\n<p>Tesamorelin contains the full 44-amino-acid human GRF sequence with an N-terminal hexenoyl modification.<\/p>\n<p>CJC-1295 with DAC uses a different modified peptide sequence and an albumin-binding Drug Affinity Complex.<\/p>\n<p>Researchers should not treat these compounds as interchangeable and should verify the exact product identity through batch-specific analytical documentation.<\/p>\n<h2>V\u00fdzkum metabolick\u00fdch drah<\/h2>\n<p>The GH\u2013IGF-1 axis interacts with multiple metabolic and endocrine systems.<\/p>\n<p>Tesamorelin may be relevant for laboratory models involving:<\/p>\n<ul>\n<li>Signalizace souvisej\u00edc\u00ed s lipidy<\/li>\n<li>Dr\u00e1hy gluk\u00f3zov\u00e9 homeost\u00e1zy<\/li>\n<li>Protein metabolism<\/li>\n<li>Hepatic signalling<\/li>\n<li>Adipocyte biology<\/li>\n<li>Endocrine\u2013metabolic communication<\/li>\n<li>Cellular energy regulation<\/li>\n<li>Hormone-responsive gene expression<\/li>\n<li>Metabolic biomarker analysis<\/li>\n<li>Comparative peptide research<\/li>\n<\/ul>\n<p>Research results can vary according to the biological model, concentration, exposure duration and analytical method.<\/p>\n<h2>Potenci\u00e1ln\u00ed v\u00fdzkumn\u00e9 aplikace<\/h2>\n<p>Tesamorelin may be suitable for controlled scientific research involving:<\/p>\n<ul>\n<li>GHRH receptor pharmacology<\/li>\n<li>Pituitary somatotroph signalling<\/li>\n<li>Endogenous growth hormone secretion<\/li>\n<li>Growth hormone pulsatility<\/li>\n<li>GH\u2013IGF-1 axis research<\/li>\n<li>Hypothalamic\u2013pituitary communication<\/li>\n<li>Endokrinn\u00ed mechanismy zp\u011btn\u00e9 vazby<\/li>\n<li>Peptide stabilisation<\/li>\n<li>N-terminal molecular modification<\/li>\n<li>Vztahy mezi strukturou a aktivitou<\/li>\n<li>Metabolick\u00e1 signalizace<\/li>\n<li>Analytick\u00e1 charakterizace peptid\u016f<\/li>\n<li>Chromatografick\u00e1 anal\u00fdza<\/li>\n<li>Anal\u00fdza hmotnostn\u00ed spektrometri\u00ed<\/li>\n<li>Testov\u00e1n\u00ed stability a degradace<\/li>\n<li>Comparative GHRH analogue research<\/li>\n<\/ul>\n<p>The receiving laboratory is responsible for determining and validating appropriate concentrations, controls and analytical procedures.<\/p>\n<h2>Analytick\u00fd v\u00fdzkum<\/h2>\n<p>Tesamorelin may be suitable for professional analytical applications involving:<\/p>\n<ul>\n<li>Vysoce v\u00fdkonn\u00e1 kapalinov\u00e1 chromatografie<\/li>\n<li>Kapalinov\u00e1 chromatografie s hmotnostn\u00ed spektrometri\u00ed<\/li>\n<li>Potvrzen\u00ed identity peptidu<\/li>\n<li>Anal\u00fdza molekulov\u00e9 hmotnosti<\/li>\n<li>Ov\u011b\u0159en\u00ed aminokyselinov\u00e9 sekvence<\/li>\n<li>Posouzen\u00ed \u010distoty<\/li>\n<li>Testov\u00e1n\u00ed stability<\/li>\n<li>Profilov\u00e1n\u00ed degradace<\/li>\n<li>Posouzen\u00ed rozpustnosti<\/li>\n<li>Porovn\u00e1n\u00ed referen\u010dn\u00edch materi\u00e1l\u016f<\/li>\n<li>Kompatibilita s formulac\u00ed<\/li>\n<li>V\u00fdvoj analytick\u00fdch metod<\/li>\n<\/ul>\n<p>Because Tesamorelin contains an N-terminal lipid modification, analytical methods should be validated specifically for this compound.<\/p>\n<h2>Specifikace produktu<\/h2>\n<table>\n<thead>\n<tr>\n<th>Charakteristika produktu<\/th>\n<th>Informace<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>N\u00e1zev produktu<\/td>\n<td>Tesamorelin<\/td>\n<\/tr>\n<tr>\n<td>Alternative designation<\/td>\n<td>TH9507<\/td>\n<\/tr>\n<tr>\n<td>Kategorie produktu<\/td>\n<td>Syntetick\u00fd v\u00fdzkumn\u00fd peptid<\/td>\n<\/tr>\n<tr>\n<td>Typ slou\u010deniny<\/td>\n<td>Stabilised GHRH analogue<\/td>\n<\/tr>\n<tr>\n<td>D\u00e9lka peptidu<\/td>\n<td>44 amino acids<\/td>\n<\/tr>\n<tr>\n<td>Struktur\u00e1ln\u00ed z\u00e1klad<\/td>\n<td>Complete human GRF 1\u201344 sequence<\/td>\n<\/tr>\n<tr>\n<td>Molekul\u00e1rn\u00ed modifikace<\/td>\n<td>N-terminal trans-3-hexenoyl group<\/td>\n<\/tr>\n<tr>\n<td>Prim\u00e1rn\u00ed c\u00edl v\u00fdzkumu<\/td>\n<td>GHRH receptor<\/td>\n<\/tr>\n<tr>\n<td>Hlavn\u00ed v\u00fdzkumn\u00e1 cesta<\/td>\n<td>R\u016fstov\u00fd hormon a osa IGF-1<\/td>\n<\/tr>\n<tr>\n<td>Approximate molecular weight<\/td>\n<td>5.1 kDa<\/td>\n<\/tr>\n<tr>\n<td>Formul\u00e1\u0159<\/td>\n<td>Lyofilizovan\u00fd v\u00fdzkumn\u00fd materi\u00e1l<\/td>\n<\/tr>\n<tr>\n<td>Prezentace<\/td>\n<td>Bezpe\u010dn\u011b uzav\u0159en\u00e1 v\u00fdzkumn\u00e1 lahvi\u010dka<\/td>\n<\/tr>\n<tr>\n<td>Dokumentace<\/td>\n<td>Analytick\u00e9 informace specifick\u00e9 pro danou \u0161ar\u017ei<\/td>\n<\/tr>\n<tr>\n<td>Obal<\/td>\n<td>Bezpe\u010dn\u00e9 a diskr\u00e9tn\u00ed balen\u00ed<\/td>\n<\/tr>\n<tr>\n<td>Zam\u00fd\u0161len\u00e9 pou\u017eit\u00ed<\/td>\n<td>V\u011bdeck\u00fd, analytick\u00fd a laboratorn\u00ed v\u00fdzkum<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Lyofilizovan\u00fd v\u00fdzkumn\u00fd form\u00e1t<\/h2>\n<p>Tesamorelin is supplied as a lyophilised research material in a securely sealed vial.<\/p>\n<p>Lyophilisation removes moisture and helps support peptide stability during controlled storage and transportation. Minor differences in physical appearance may occur because of product quantity, production conditions and residual moisture.<\/p>\n<p>Physical appearance alone should not be used to establish product identity, purity or analytical quality. Researchers should review the documentation associated with the applicable batch before beginning laboratory work.<\/p>\n<h2>Kvalita a transparentnost produkt\u016f<\/h2>\n<p>Peptides Divas focuses on clearly displayed product specifications, professional handling and batch-level traceability.<\/p>\n<p>Dostupn\u00e9 analytick\u00e9 informace mohou zahrnovat:<\/p>\n<ul>\n<li>Identifikace produktu<\/li>\n<li>Peptidov\u00e1 sekvence<\/li>\n<li>\u010c\u00edslo \u0161ar\u017ee nebo \u0161ar\u017ee<\/li>\n<li>Uv\u00e1d\u011bn\u00e1 \u010distota<\/li>\n<li>HPLC anal\u00fdza<\/li>\n<li>Data hmotnostn\u00ed spektrometrie<\/li>\n<li>Molecular-weight information<\/li>\n<li>Informace o testov\u00e1n\u00ed<\/li>\n<li>Vzhled produktu<\/li>\n<li>Doporu\u010den\u00ed pro skladov\u00e1n\u00ed<\/li>\n<\/ul>\n<p>To poskytuje v\u00fdzkumn\u00edk\u016fm jasn\u00e9 a sledovateln\u00e9 informace o p\u0159\u00edslu\u0161n\u00e9 \u0161ar\u017ei produktu.<\/p>\n<h2>Informace o \u00falo\u017ei\u0161ti<\/h2>\n<p>Store Tesamorelin in its original sealed packaging according to the conditions displayed on the product label and applicable batch documentation.<\/p>\n<p>Protect the research material from:<\/p>\n<ul>\n<li>P\u0159\u00edm\u00e9 slune\u010dn\u00ed sv\u011btlo<\/li>\n<li>Nadm\u011brn\u00e9 teplo<\/li>\n<li>Vlhkost<\/li>\n<li>Kontaminace<\/li>\n<li>Po\u0161kozen\u00fd obal<\/li>\n<li>Opakovan\u00e9 teplotn\u00ed v\u00fdkyvy<\/li>\n<li>Zbyte\u010dn\u00e9 vystaven\u00ed vzduchu<\/li>\n<\/ul>\n<p>P\u0159ij\u00edmaj\u00edc\u00ed laborato\u0159 je zodpov\u011bdn\u00e1 za stanoven\u00ed vhodn\u00fdch postup\u016f p\u0159\u00edpravy, manipulace a skladov\u00e1n\u00ed pro sv\u016fj specifick\u00fd v\u00fdzkumn\u00fd protokol.<\/p>\n<h2>Why Choose Tesamorelin?<\/h2>\n<p>Tesamorelin provides a clearly defined and stabilised full-length GHRH analogue for advanced receptor and endocrine research.<\/p>\n<p>Key research advantages include:<\/p>\n<ul>\n<li>Complete 44-amino-acid human GRF sequence<\/li>\n<li>Specialised N-terminal hexenoyl modification<\/li>\n<li>Relevantn\u00ed pro studie receptor\u016f GHRH<\/li>\n<li>Suitable for pituitary signalling research<\/li>\n<li>Useful for GH\u2013IGF-1 axis models<\/li>\n<li>Valuable for peptide-stability analysis<\/li>\n<li>Suitable for comparative GHRH research<\/li>\n<li>Pohodln\u00e1 lyofilizovan\u00e1 prezentace<\/li>\n<li>Jasn\u00e9 informace o produktu specifick\u00e9 pro danou \u0161ar\u017ei<\/li>\n<\/ul>\n<h2>Pro\u010d objedn\u00e1vat od Peptides Divas?<\/h2>\n<p>Peptides Divas combines carefully selected research materials with fast, dependable and professional service.<\/p>\n<p>Customers benefit from:<\/p>\n<ul>\n<li>Jasn\u011b zobrazen\u00e9 specifikace produktu<\/li>\n<li>Analytick\u00e9 informace specifick\u00e9 pro danou \u0161ar\u017ei<\/li>\n<li>Rychl\u00e9 zpracov\u00e1n\u00ed objedn\u00e1vky<\/li>\n<li>Bezpe\u010dn\u00e9 a diskr\u00e9tn\u00ed balen\u00ed<\/li>\n<li>Mo\u017enosti sledovateln\u00e9 dopravy<\/li>\n<li>Pe\u010dliv\u00e1 ochrana lahvi\u010dky<\/li>\n<li>Responzivn\u00ed z\u00e1kaznick\u00e1 podpora<\/li>\n<li>Spolehliv\u00e9 evropsk\u00e9 doru\u010den\u00ed<\/li>\n<\/ul>\n<p>Choose Tesamorelin from Peptides Divas for advanced laboratory research involving GHRH receptor activity, pituitary signalling, the GH\u2013IGF-1 axis and stabilised peptide design.<\/p>\n<p>Pouze pro laboratorn\u00ed v\u00fdzkumn\u00e9 pou\u017eit\u00ed. Nen\u00ed ur\u010deno pro hum\u00e1nn\u00ed ani veterin\u00e1rn\u00ed pou\u017eit\u00ed.<\/p>","protected":false},"excerpt":{"rendered":"<p class=\"isSelectedEnd\">Tesamorelin is a synthetic and stabilised 44-amino-acid analogue of human growth hormone-releasing hormone.<\/p>\n<p class=\"isSelectedEnd\">Its specialised N-terminal hexenoyl modification makes it particularly relevant for advanced laboratory research involving GHRH receptor activity, pituitary signalling, endogenous growth hormone release, the GH\u2013IGF-1 axis and peptide stability.<\/p>\n<p>Dod\u00e1v\u00e1 se jako pr\u00e9miov\u00fd lyofilizovan\u00fd v\u00fdzkumn\u00fd materi\u00e1l s jasn\u00fdmi informacemi o \u0161ar\u017ei, bezpe\u010dn\u00fdm balen\u00edm a rychl\u00fdm a sledovateln\u00fdm doru\u010den\u00edm.<\/p>","protected":false},"featured_media":143,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false,"nf_dc_page":"","om_disable_all_campaigns":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0},"product_brand":[],"product_cat":[36],"product_tag":[46],"class_list":["post-149","product","type-product","status-publish","has-post-thumbnail","product_cat-growth-hormone-pathway-peptides","product_tag-10-mg","first","instock","shipping-taxable","purchasable","product-type-simple"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.9 (Yoast SEO v28.0) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Tesamorelin Research Peptide | Peptides Divas<\/title>\n<meta name=\"description\" content=\"Explore Tesamorelin, a stabilised 44-amino-acid GHRH analogue for advanced research involving pituitary signalling and the GH\u2013IGF-1 axis.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/peptidesdivas.com\/cs\/product\/tesamorelin-research-peptide-peptides-divas\/\" \/>\n<meta property=\"og:locale\" content=\"cs_CZ\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Tesamorelin\" \/>\n<meta property=\"og:description\" content=\"Explore Tesamorelin, a stabilised 44-amino-acid GHRH analogue for advanced research involving pituitary signalling and the GH\u2013IGF-1 axis.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/peptidesdivas.com\/cs\/product\/tesamorelin-research-peptide-peptides-divas\/\" \/>\n<meta property=\"og:site_name\" content=\"Peptides Divas\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-20T08:32:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/peptidesdivas.com\/wp-content\/uploads\/2026\/06\/Tesamorelin.jpeg\" \/>\n\t<meta property=\"og:image:width\" content=\"1179\" \/>\n\t<meta property=\"og:image:height\" content=\"1169\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Odhadovan\u00e1 doba \u010dten\u00ed\" \/>\n\t<meta name=\"twitter:data1\" content=\"7 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/peptidesdivas.com\\\/product\\\/tesamorelin-research-peptide-peptides-divas\\\/\",\"url\":\"https:\\\/\\\/peptidesdivas.com\\\/product\\\/tesamorelin-research-peptide-peptides-divas\\\/\",\"name\":\"Tesamorelin Research Peptide | Peptides Divas\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/lgo.ebt.mybluehost.me\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/peptidesdivas.com\\\/product\\\/tesamorelin-research-peptide-peptides-divas\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/peptidesdivas.com\\\/product\\\/tesamorelin-research-peptide-peptides-divas\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/i0.wp.com\\\/peptidesdivas.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Tesamorelin.jpeg?fit=1179%2C1169&ssl=1\",\"datePublished\":\"2026-06-18T00:09:00+00:00\",\"dateModified\":\"2026-07-20T08:32:05+00:00\",\"description\":\"Explore Tesamorelin, a stabilised 44-amino-acid GHRH analogue for advanced research involving pituitary signalling and the GH\u2013IGF-1 axis.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/peptidesdivas.com\\\/product\\\/tesamorelin-research-peptide-peptides-divas\\\/#breadcrumb\"},\"inLanguage\":\"cs\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/peptidesdivas.com\\\/product\\\/tesamorelin-research-peptide-peptides-divas\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"cs\",\"@id\":\"https:\\\/\\\/peptidesdivas.com\\\/product\\\/tesamorelin-research-peptide-peptides-divas\\\/#primaryimage\",\"url\":\"https:\\\/\\\/i0.wp.com\\\/peptidesdivas.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Tesamorelin.jpeg?fit=1179%2C1169&ssl=1\",\"contentUrl\":\"https:\\\/\\\/i0.wp.com\\\/peptidesdivas.com\\\/wp-content\\\/uploads\\\/2026\\\/06\\\/Tesamorelin.jpeg?fit=1179%2C1169&ssl=1\",\"width\":1179,\"height\":1169},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/peptidesdivas.com\\\/product\\\/tesamorelin-research-peptide-peptides-divas\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/peptidesdivas.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Shop\",\"item\":\"https:\\\/\\\/peptidesdivas.com\\\/shop\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Tesamorelin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/lgo.ebt.mybluehost.me\\\/#website\",\"url\":\"https:\\\/\\\/lgo.ebt.mybluehost.me\\\/\",\"name\":\"Peptides Divas\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/lgo.ebt.mybluehost.me\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"cs\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Tesamorelin Research Peptide | Peptides Divas","description":"Explore Tesamorelin, a stabilised 44-amino-acid GHRH analogue for advanced research involving pituitary signalling and the GH\u2013IGF-1 axis.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/peptidesdivas.com\/cs\/product\/tesamorelin-research-peptide-peptides-divas\/","og_locale":"cs_CZ","og_type":"article","og_title":"Tesamorelin","og_description":"Explore Tesamorelin, a stabilised 44-amino-acid GHRH analogue for advanced research involving pituitary signalling and the GH\u2013IGF-1 axis.","og_url":"https:\/\/peptidesdivas.com\/cs\/product\/tesamorelin-research-peptide-peptides-divas\/","og_site_name":"Peptides Divas","article_modified_time":"2026-07-20T08:32:05+00:00","og_image":[{"width":1179,"height":1169,"url":"https:\/\/peptidesdivas.com\/wp-content\/uploads\/2026\/06\/Tesamorelin.jpeg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Odhadovan\u00e1 doba \u010dten\u00ed":"7 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/peptidesdivas.com\/product\/tesamorelin-research-peptide-peptides-divas\/","url":"https:\/\/peptidesdivas.com\/product\/tesamorelin-research-peptide-peptides-divas\/","name":"Tesamorelin Research Peptide | Peptides Divas","isPartOf":{"@id":"https:\/\/lgo.ebt.mybluehost.me\/#website"},"primaryImageOfPage":{"@id":"https:\/\/peptidesdivas.com\/product\/tesamorelin-research-peptide-peptides-divas\/#primaryimage"},"image":{"@id":"https:\/\/peptidesdivas.com\/product\/tesamorelin-research-peptide-peptides-divas\/#primaryimage"},"thumbnailUrl":"https:\/\/i0.wp.com\/peptidesdivas.com\/wp-content\/uploads\/2026\/06\/Tesamorelin.jpeg?fit=1179%2C1169&ssl=1","datePublished":"2026-06-18T00:09:00+00:00","dateModified":"2026-07-20T08:32:05+00:00","description":"Explore Tesamorelin, a stabilised 44-amino-acid GHRH analogue for advanced research involving pituitary signalling and the GH\u2013IGF-1 axis.","breadcrumb":{"@id":"https:\/\/peptidesdivas.com\/product\/tesamorelin-research-peptide-peptides-divas\/#breadcrumb"},"inLanguage":"cs","potentialAction":[{"@type":"ReadAction","target":["https:\/\/peptidesdivas.com\/product\/tesamorelin-research-peptide-peptides-divas\/"]}]},{"@type":"ImageObject","inLanguage":"cs","@id":"https:\/\/peptidesdivas.com\/product\/tesamorelin-research-peptide-peptides-divas\/#primaryimage","url":"https:\/\/i0.wp.com\/peptidesdivas.com\/wp-content\/uploads\/2026\/06\/Tesamorelin.jpeg?fit=1179%2C1169&ssl=1","contentUrl":"https:\/\/i0.wp.com\/peptidesdivas.com\/wp-content\/uploads\/2026\/06\/Tesamorelin.jpeg?fit=1179%2C1169&ssl=1","width":1179,"height":1169},{"@type":"BreadcrumbList","@id":"https:\/\/peptidesdivas.com\/product\/tesamorelin-research-peptide-peptides-divas\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/peptidesdivas.com\/"},{"@type":"ListItem","position":2,"name":"Shop","item":"https:\/\/peptidesdivas.com\/shop\/"},{"@type":"ListItem","position":3,"name":"Tesamorelin"}]},{"@type":"WebSite","@id":"https:\/\/lgo.ebt.mybluehost.me\/#website","url":"https:\/\/lgo.ebt.mybluehost.me\/","name":"Peptidy Divas","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/lgo.ebt.mybluehost.me\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"cs"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/peptidesdivas.com\/cs\/wp-json\/wp\/v2\/product\/149","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/peptidesdivas.com\/cs\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/peptidesdivas.com\/cs\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/peptidesdivas.com\/cs\/wp-json\/wp\/v2\/comments?post=149"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/peptidesdivas.com\/cs\/wp-json\/wp\/v2\/media\/143"}],"wp:attachment":[{"href":"https:\/\/peptidesdivas.com\/cs\/wp-json\/wp\/v2\/media?parent=149"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/peptidesdivas.com\/cs\/wp-json\/wp\/v2\/product_brand?post=149"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/peptidesdivas.com\/cs\/wp-json\/wp\/v2\/product_cat?post=149"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/peptidesdivas.com\/cs\/wp-json\/wp\/v2\/product_tag?post=149"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}